Showing results (71-80 of 315) with videos related to
Sort By:
Pageof 32
Drugs|July 6, 2000
COX-2 selective nonsteroidal anti-Inflammatory drugs: do they really offer any advantages?L M Jackson, C J HawkeyThe American Journal of Medicine|February 13, 2001
Questions regarding future research on aspirin and the gastrointestinal tractB I Hirschowitz, C J HawkeyInternational Journal of Clinical Practice|June 13, 2003
COX-LOX inhibition: current evidence for an emerging new therapyM M Skelly, C J HawkeyBailliere'S Clinical Gastroenterology|June 1, 1994
Treatment of inflammatory bowel disease from now to the millenniumA T Cole, C J HawkeyAlimentary Pharmacology & Therapeutics|April 1, 1997
Review article: COX-II inhibitors--a new generation of safer NSAIDs?M T Donnelly, C J HawkeyDrugs|August 1, 1989
Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapyA B Hawthorne, C J HawkeyDigestive Diseases (Basel, Switzerland)|January 1, 1989
Aspirin and gastroduodenal injuryP J Prichard, C J HawkeyCurrent Pharmaceutical Design|October 8, 2003
Dual COX inhibition and upper gastrointestinal damageM M Skelly, C J HawkeyCurrent Pharmaceutical Design|April 12, 2002
Gastrointestinal safety of selective COX-2 inhibitorsC J Hawkey, M M SkellyLancet (London, England)|November 8, 1986
Prostaglandins for peptic ulcer: a promise unfulfilledC J Hawkey, R P WaltPageof 32